Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil
Open Access
- 28 March 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 27 (5) , 344-351
Abstract
Background: Breast cancer outcomes among patients who use safety-net hospitals in the highly populated Harris County, Texas and Southeast Brazil are poor. It is unknown whether treatment delay contributes to these outcomes. Methods: We conducted a retrospective cohort analysis of patients with non-metastatic breast cancer diagnosed between January 1, 2009 and December 31, 2011 at Harris Health Texas and Unicamp’s Women’s Hospital, Barretos Hospital, and Brazilian National Institute of Cancer, Brazil. We used Cox proportional hazards regression to evaluate association of time to treatment and risk of recurrence (ROR) or death. Results: One thousand one hundred ninety-one patients were included. Women in Brazil were more frequently diagnosed with stage III disease (32.3% vs. 21.1% Texas; P = .002). Majority of patients in both populations had symptom-detected disease (63% in Brazil vs. 59% in Texas). Recurrence within 5 years from diagnosis was similar 21% versus 23%. Median time from diagnosis to first treatment defined as either systemic therapy (chemotherapy or endocrine therapy) or surgery, were comparable, 9.9 weeks versus 9.4 weeks. Treatment delay was not associated with increased ROR or death. Higher stage at diagnosis was associated with both increased ROR and death. Conclusion: Time from symptoms to treatment was considerably long in both populations. Treatment delay did not affect outcomes. Impact: Access to timely screening and diagnosis of breast cancer are priorities in these populations.Keywords
Funding Information
- Lester and Sue Smith Breast Center
- T32 Institutional Training Grant
- Susan G. Komen Travel Scholarship
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Brasil Finance Code
This publication has 55 references indexed in Scilit:
- Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital - a closer look into cause-specific mortalityBMC Cancer, 2013
- Delays in diagnosis and treatment of breast cancer: a multinational analysisEuropean Journal of Public Health, 2013
- Diagnosis delay in Libyan female breast cancerBMC Research Notes, 2012
- The effect of delays in treatment for breast cancer metastasis on survivalBreast Cancer Research and Treatment, 2011
- Expansion of cancer care and control in countries of low and middle income: a call to actionThe Lancet, 2010
- Identification of racial disparities in breast cancer mortality: does scale matter?International Journal of Health Geographics, 2010
- Prognostic implications of emergency admission and delays in patients with breast cancerSupportive Care in Cancer, 2008
- Breast Cancer Survival among Economically Disadvantaged Women: The Influences of Delayed Diagnosis and Treatment on MortalityCancer Epidemiology, Biomarkers & Prevention, 2008
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLOS Medicine, 2006
- Prognostic and Predictive Factors in Early-Stage Breast CancerThe Oncologist, 2004